Engineers develop AI tool to design peptides that turn signals on or off

In computational analyses, TD3B generated agonists and antagonists that would contact the key activation and deactivation sites used by known GLP-1 drugs, without ever being…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *